Skip to main content
. Author manuscript; available in PMC: 2019 Feb 13.
Published in final edited form as: Nat Genet. 2018 Aug 13;50(9):1219–1224. doi: 10.1038/s41588-018-0183-z

Table 3.

Prevalence and clinical impact of a high GPS

High GPS definition Reference group Odds ratio 95% CI P value
CAD
Top 20% of distribution Remaining 80% 2.55 2.43–2.67 <1 × 10−300
Top 10% of distribution Remaining 90% 2.89 2.74–3.05 <1 × 10−300
Top 5% of distribution Remaining 95% 3.34 3.12–3.58 6.5 × 10−264
Top 1% of distribution Remaining 99% 4.83 4.25–5.46 1.0 × 10−132
Top 0.5% of distribution Remaining 99.5% 5.17 4.34–6.12 7.9 × 10−78
Atrial fibrillation
Top 20% of distribution Remaining 80% 2.43 2.29–2.59 2.1 × 10−177
Top 10% of distribution Remaining 90% 2.74 2.55–2.94 7.0 × 10−169
Top 5% of distribution Remaining 95% 3.22 2.95–3.51 1.1 × 10−152
Top 1% of distribution Remaining 99% 4.63 3.96–5.39 2.9 × 10−84
Top 0.5% of distribution Remaining 99.5% 5.23 4.24–6.39 3.5 × 10−56
Type 2 diabetes
Top 20% of distribution Remaining 80% 2.33 2.20–2.46 3.1 × 10−201
Top 10% of distribution Remaining 90% 2.49 2.34–2.66 1.2 × 10−167
Top 5% of distribution Remaining 95% 2.75 2.53–2.98 1.7 × 10−130
Top 1% of distribution Remaining 99% 3.30 2.81–3.85 1.4 × 10−49
Top 0.5% of distribution Remaining 99.5% 3.48 2.79–4.29 4.3 × 10−30
Inflammatory bowel disease
Top 20% of distribution Remaining 80% 2.19 2.03–2.36 7.7 × 10−95
Top 10% of distribution Remaining 90% 2.43 2.22–2.65 8.8 × 10−88
Top 5% of distribution Remaining 95% 2.66 2.38–2.96 3.0 × 10−68
Top 1% of distribution Remaining 99% 3.87 3.18–4.66 1.4 × 10−43
Top 0.5% of distribution Remaining 99.5% 4.81 3.74–6.08 9.0 × 10−37
Breast cancer
Top 20% of distribution Remaining 80% 2.07 1.97–2.19 3.4 × 10−159
Top 10% of distribution Remaining 90% 2.32 2.18–2.48 2.3 × 10−148
Top 5% of distribution Remaining 95% 2.55 2.35–2.76 2.1 × 10−112
Top 1% of distribution Remaining 99% 3.36 2.88–3.91 1.3 × 10−54
Top 0.5% of distribution Remaining 99.5% 3.83 3.11–4.68 8.2 × 10−38

Odds ratios were calculated by comparing those with high GPS with the remainder of the population in a logistic regression model adjusted for age, sex, genotyping array, and the first four principal components of ancestry. The breast cancer analysis was restricted to female participants. CI, confidence interval.